Monday, 16 December 2019

Drug Discovery News

  • Australia ideal for early-stage drug development

    Drug Discovery |  Opinion | By BioSpectrum Bureau  | 0 Comment | 14 Jun, 2012

    Australia has a long history in biomedical research, with a reputation for excellence and invention since the early 1900s. This history includes a notable sprinkling of Nobel Prize winners,...Read more

  • HUYA, Sanzao Park partner for drug development

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Singapore: HUYA Bioscience, a leader in globalizing China's biopharmaceutical innovations, has signed a strategic partnership with Zhuhai Sanzao Science and Technology Industrial Park. The ...Read more

  • GSK's cancer drug gets EU marketing authorization

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 16 Aug, 2013

    Singapore: European Commission has granted an additional indication for GlaxoSmithKline's Tyverb (lapatinib) to be used in combination with trastuzumab. This combination is indicated for a...Read more

  • Astellas completes patient recruitment in drug trial

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Dec, 2012

    Singapore: Japanese company Astellas Pharma has completed patient recruitment for the isavuconazole phase III registration study SECURE. Isavuconazole is an investigational intravenous (IV)...Read more

  • Daiichi Sankyo expands drug discovery program

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2013

    Singapore: Japan-based Daiichi Sankyo has decided to expand its collaborative drug discovery program with universities and research institutions based in Japan, 'Take a New challenge for Dr...Read more

  • Boehringer terminates insulin deal with Lilly

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jan, 2013

    Singapore: Eli Lilly and Boehringer Ingelheim are making a slight adjustment to their diabetes alliance with respect to LY2605541, Lilly's novel basal insulin analog. Lilly is re-assuming ...Read more

  • Cellmid gets positive sign with Midkine antibody for kidney disease

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Australia's Cellmid has completed its first in-life diabetic nephropathy study with anti-midkine antibodies (MK-Ab) in a mouse model of the disease. Two of Cellmid's proprietary ...Read more

  • Takeda Gemini II trial shows positive results

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2012

    Singapore: Positive results were reported from Takeda Pharmaceutical's international, randomized, placebo-controlled, double-blind GEMINI II pivotal phase III trial. The trial evaluated v...Read more

  • IOF, Fonterra grants $43K to Indonesian for bone R&D

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2013

    Singapore: Global organization, International Osteoporosis Foundation (IOF), and New Zealand dairy firm, Fonterra have come together to fund and support research on female bone health in In...Read more

  • Vanda Pharma withdraws application for Fanaptum

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

    Singapore: Vanda Pharmaceuticals has withdrawn its application from European Medicines Agency for a centralized marketing authorization for the medicine Fanaptum (iloperidone) intended to b...Read more

  • AbbVie invests $320 mn in bilogics manufacturing in Singapore

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Research based pharmaceutical company, AbbVie, has made investment of around USD320 million in Singapore to set up small molecule and biologics active drug substance manufacturin...Read more

  • Prana Alzheimer's trial shows +ve results

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Apr, 2013

    Singapore: Prana Biotechnology reported on the progress of its lead development asset PBT2, which is in phase II trials for Huntington disease and Alzheimer's disease. Across the two trials...Read more

  • Astellas to do interim analysis of cancer trial

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Apr, 2013

    Singapore: Medivation and Astellas Pharma have established an updated interim analysis plan for the Prevail trial, a global phase III clinical trial evaluating Xtandi (enzalutamide) capsule...Read more

  • Novartis acquires cancer firm CoStim

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Feb, 2014

    Singapore: Global pharmaceutical firm, Novartis, has acquired CoStim Pharmaceuticals, a privately held biotechnology company, broadening its cancer immunotherapy research program. Increasi...Read more

  • Cytos reveals trial data allergic asthma immune modulator

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Sep, 2013

    Singapore: Cytos Biotechnology revealed additional results of the phase IIa clinical trial with CYT003, a first-in-class immune modulator in clinical development as a potential new treatmen...Read more

  • Prism to start PRI-724 trials to treat fibrosis

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 Jun, 2013

    Singapore: Prism Pharma, a drug discovery company focused on developing small molecule technologies that modulate protein-protein interactions, announced the close of an approximately $15 m...Read more

  • Boehringer, Eli Lilly reveal post-hoc results for linagliptin

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Singapore: Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company revealed results from a post-hoc analysis, which explored the clinical effect of linagliptin on albuminuria in pati...Read more

  • Bayer recognizes innovation by Korean start-up

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Aug, 2016

    Singapore: Vital Smith, a Korean startup which focuses on developing innovative technology for diagnostics devices is recognized and acknowledged by Bayer as the final winners of its Grant...Read more



Podcast

 

Survey Box

Is APAC region emerging as a leader in assistive technologies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls